Ameriprise Financial Inc. Has $74.25 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Ameriprise Financial Inc. boosted its holdings in Encompass Health Co. (NYSE:EHC) by 0.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 804,029 shares of the company’s stock after purchasing an additional 6,557 shares during the period. Ameriprise Financial Inc.’s holdings in Encompass Health were worth $74,252,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of EHC. T. Rowe Price Investment Management Inc. bought a new position in Encompass Health during the fourth quarter worth $152,953,000. Norges Bank bought a new position in shares of Encompass Health during the 4th quarter worth about $100,637,000. Raymond James Financial Inc. acquired a new position in shares of Encompass Health during the fourth quarter valued at about $77,944,000. Jennison Associates LLC bought a new stake in shares of Encompass Health in the fourth quarter valued at about $52,094,000. Finally, AQR Capital Management LLC grew its position in Encompass Health by 136.8% during the fourth quarter. AQR Capital Management LLC now owns 689,206 shares of the company’s stock worth $63,648,000 after buying an additional 398,154 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the sale, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This trade represents a 11.15 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 19,321 shares of company stock worth $2,142,452. 2.00% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have commented on EHC. KeyCorp raised their price objective on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, April 25th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 3rd. UBS Group lifted their target price on shares of Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Finally, Royal Bank of Canada raised their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average price target of $120.86.

Encompass Health Price Performance

NYSE:EHC opened at $116.45 on Friday. The firm has a market cap of $11.74 billion, a PE ratio of 26.11, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The company’s 50-day moving average price is $103.44 and its two-hundred day moving average price is $99.93. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 12 month low of $82.74 and a 12 month high of $118.27.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.12 EPS. On average, equities analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health’s dividend payout ratio is currently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.